Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Ondansetron 4 MG
Total 0 results
Nothing found
Sponsors and Collaborators
Paul W. Read, MD
Epicentre, Paris, France.
Carlos III Health Institute
Zhijun Sun
Sociedad Española de Arteriosclerosis
Australian Childhood Foundation
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
wenbinlu
Laboratoires Iprad-Vegebom
Health Holding Company, Hail Health Cluster, Saudi Arabia
Remedy Institute
Resurge Therapeutics Inc.
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Brigham and Womens' Hospital, Center for Surgery and Public Health
Prader-Willi Syndrome Association of Australia
Sonogenix
The Depressive and Bipolar Disorder Alternative Treatment Foundation
NATURAmedicatrix Sàrl
Kettering Foundation
View Full List
Medical Conditions
Intervention Studies
Cell Senescence
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Stroke Recrudescence
Adherence to In-Office Glaucoma Evaluation Appointment
Escape Room Games and Role Playing Gamification
Pregnancy; Accident
Mycobacterium Avium Complex Infections
Marginal Zone B-cell Lymphoma
Stage III Childhood Anaplastic Large Cell Lymphoma
Refractory B-Lineage Lymphoma
Hernia,Ventral
Malignant Tumor of Extrahepatic Bile Duct
Stage IIIB Esophageal Adenocarcinoma
Psychoactive Substance Use
Ankle Trauma
Neurobehavioral Manifestation
Spinocerebellar Ataxia Genotype Type 3
Apneic; Oxygenation
Lymphoblastic Lymphoma
View Full List
Drug Interventions
Lansoprazole 15mg QD
Colecalciferol D3 (Vigantol Oil)
Everolimus
Optiva artificial tear by Allergan
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
SBI-087
Omeprazole 40 mg
300 mg of caffeine citrate infusion
Oral Aztreonam
LINjeta U-100 Insulin
Epalrestat
Fostamatinib
Fenofibric acid 135mg
Gadoteridol (ProHance)
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
ART-123
FRSW107
Irinotecan
Triple therapy
Low molecular weight Heparin as standard of care treatment
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Belgium
Contract Research Organizations in Brazil
Contract Research Organizations in Estonia
Contract Research Organizations in Kosovo
Contract Research Organizations in Malaysia
Contract Research Organizations in Mozambique
Contract Research Organizations in Panama
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in South Africa
Contract Research Organizations in Tunisia
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Tunisia
ACROSS Global
SGS
Keyrus Life Science
MCT
Clinica Group
Nagy Research
Mesned CRO
All CROs in Tunisia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe